DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.

Area of Science:

• Immunology
• Cell Biology
• Periodontology

Background:

• Dendritic cell-specific transmembrane protein (DC-STAMP) is crucial for osteoclast (OC) fusion and immune regulation.
• DC-STAMP expression is elevated in periodontitis, but its role in the disease is unclear.

Purpose of the Study:

• To investigate the role of DC-STAMP in ligature-induced periodontitis.
• To evaluate the therapeutic potential of anti-DC-STAMP monoclonal antibody (mAb) in preventing periodontal bone loss.

Main Methods:

• A mouse model of ligature-induced periodontitis was used.
• Anti-DC-STAMP-mAb was administered systemically and locally.
• Osteoclastogenesis, cell fusion, and periodontal bone loss were assessed.
• Immune responses to Pasteurella pneumotropica were evaluated.

Main Results:

• DC-STAMP is expressed on osteoclasts and involved in late-stage cell fusion.
• Anti-DC-STAMP-mAb inhibited osteoclast fusion and bone resorption in vitro.
• Ligature-induced periodontitis led to increased DC-STAMP expression, osteoclastogenesis, and alveolar bone loss.
• Both systemic and local administration of anti-DC-STAMP-mAb significantly reduced bone loss and osteoclast numbers.
• Anti-DC-STAMP-mAb did not affect anti-bacterial immune responses.

Conclusions:

• DC-STAMP plays a significant role in promoting osteoclast fusion and periodontal bone loss.
• Targeting DC-STAMP represents a potential therapeutic strategy for periodontitis.
• DC-STAMP inhibition offers a localized approach to managing periodontal bone destruction without impacting systemic immunity.